chris

Indovac vaccine approved “as a primary vaccine for adults”

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

The Indovac vaccine, developed by Indonesia’s state-owned pharmaceutical company Bio Farma and the Texas Children’s Hospital Centre for Vaccine Development at Baylor College of Medicine, has been approved “as a primary vaccine for adults,” according to CNN Indonesia. www.medscape.com/viewarticle/981547?src=wnl_edit_tpal&uac=398271FG&impID=4700521&faf=1 Bio Farma says it will produce 20 million doses of the vaccine in 2022 and 100 […]

Indovac vaccine approved “as a primary vaccine for adults” Read More »

Global Fund receives $14.25 billion pledge to help reverse setbacks caused by COVID-19

Leave a Comment / Featured, infectious diseases, Malaria, News, Paludisme / chris

High- and low-income countries alike last week joined in pledging $14.25 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria, in the largest single fundraising push for global health. www.science.org/content/article/news-glance-earth-science-satellites-global-fund-s-haul-and-neptune-s-rings? Supporters said the sum was necessary to help reverse setbacks in combating those diseases caused by the COVID-19 pandemic, although the amount fell

Global Fund receives $14.25 billion pledge to help reverse setbacks caused by COVID-19 Read More »

BRAIN research to map cells of human brain

Leave a Comment / Featured, News / chris

www.science.org/content/article/nihs-brain-initiative-puts-dollar500-million-creating-detailed-ever-human-brain-atlas The Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative, the 9-year-old, multibillion-dollar US neuroscience effort, has announced its most ambitious challenge yet: compiling the world’s most comprehensive map of cells in the human brain. Scientists say the BRAIN Initiative Cell Atlas Network (BICAN), funded with $500 million over 5 years, will help them understand

BRAIN research to map cells of human brain Read More »

Most common current COVID lineages now derive from Omicron strain

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

Last year, the World Health Organization (WHO) began assigning Greek letters to worrying new variants of the coronavirus. The organization started with Alpha and swiftly worked its way through the Greek alphabet in the months that followed. When Omicron arrived in November, it was the 13th named variant in less than a year. But 10

Most common current COVID lineages now derive from Omicron strain Read More »

Countries across Asia open borders post-COVID

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

After two-and-a-half years of tight pandemic controls, some of Asia’s last holdouts are opening their borders, as they move to bolster their economies and play catch-up with a world that has largely learned to live with COVID. Hong Kong said on Friday that it would abandon mandatory hotel quarantine for people coming to the city starting next week,

Countries across Asia open borders post-COVID Read More »

A new generation of inhaled COVID vaccines

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

A new generation of COVID-19 vaccines that can be inhaled or sprayed up the nose—instead of taken by injection—will begin rolling out in Asia, though just how effective they are remains to be seen. Regulators in China and India have greenlighted distribution of vaccines delivered through the mouth or nose, a delivery that scientists say

A new generation of inhaled COVID vaccines Read More »

Khosta-2, the next pandemic?

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

A Covid-like virus lurking in Russian bats could jump to humans, scientists warned today. American virologists who carried out experiments on the pathogen — called Khosta-2 — fear it is ‘completely resistant’ to vaccines deployed during the pandemic. They found it was able to latch onto human cells with ease in the same way as

Khosta-2, the next pandemic? Read More »

COVID cases in the UK begin to rise

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

COVID cases in England and Wales have risen for the first time in two months – marking an end to a steady fall since early July. The increase means the total number of infections in the UK has also gone up, but levels are estimated to have fallen in Scotland and Northern Ireland. About 927,900

COVID cases in the UK begin to rise Read More »

Nigeria to build new vaccine plant

Leave a Comment / Featured, infectious diseases, News, Nigeria / chris

Nigeria will start building a vaccine plant by end of the year after signing a contract manufacturing agreement with the Serum Institute of India for local production of the jabs, the country’s health minister said. The country struck the deal with the world’s biggest vaccine manufacturer on Wednesday, Health Minister Osagie Ehanire said at a

Nigeria to build new vaccine plant Read More »

China reports first case of monkeypox

Leave a Comment / Featured, infectious diseases, News / chris

China reported its first case of monkeypox, imported to the giant municipality of Chongqing, as the country continues its long and arduous battle against Covid-19. The patient was immediately put into quarantine after arriving in Chongqing and the risk of an outbreak is low, the local health commission said in a statement on its website

China reports first case of monkeypox Read More »

Pandemic Latest News

Author name: chris

Indovac vaccine approved “as a primary vaccine for adults”

Global Fund receives $14.25 billion pledge to help reverse setbacks caused by COVID-19

BRAIN research to map cells of human brain

Most common current COVID lineages now derive from Omicron strain

Countries across Asia open borders post-COVID

A new generation of inhaled COVID vaccines

Khosta-2, the next pandemic?

COVID cases in the UK begin to rise

About Us

Newsletter